Should patients with ovarian cancer receive intraperitoneal chemotherapy following initial cytoreductive surgery? Other Scholarly Work

Runowicz, Carolyn. (2006). Should patients with ovarian cancer receive intraperitoneal chemotherapy following initial cytoreductive surgery? . 3(8), 416-417. 10.1038/ncponc0556

keywords

  • CARBOPLATIN
  • CISPLATIN
  • GYNECOLOGIC-ONCOLOGY-GROUP
  • Life Sciences & Biomedicine
  • Oncology
  • PACLITAXEL
  • PHASE-III TRIAL
  • Science & Technology
  • cisplatin
  • intraperitoneal therapy
  • ovarian cancer
  • paclitaxel
  • survival

Digital Object Identifier (DOI)

publisher

  • NATURE PUBLISHING GROUP

start page

  • 416

end page

  • 417

volume

  • 3

issue

  • 8